These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22384821)

  • 1. Pharmacometabonomic investigation of dynamic metabolic phenotypes associated with variability in response to galactosamine hepatotoxicity.
    Coen M; Goldfain-Blanc F; Rolland-Valognes G; Walther B; Robertson DG; Holmes E; Lindon JC; Nicholson JK
    J Proteome Res; 2012 Apr; 11(4):2427-40. PubMed ID: 22384821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic aspects and novel biomarkers of responder and non-responder phenotypes in galactosamine-induced hepatitis.
    Coen M; Want EJ; Clayton TA; Rhode CM; Hong YS; Keun HC; Cantor GH; Metz AL; Robertson DG; Reily MD; Holmes E; Lindon JC; Nicholson JK
    J Proteome Res; 2009 Nov; 8(11):5175-87. PubMed ID: 19821561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism of galactosamine toxicity revisited; a metabonomic study.
    Coen M; Hong YS; Clayton TA; Rohde CM; Pearce JT; Reily MD; Robertson DG; Holmes E; Lindon JC; Nicholson JK
    J Proteome Res; 2007 Jul; 6(7):2711-9. PubMed ID: 17580851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacometabonomic characterization of xenobiotic and endogenous metabolic phenotypes that account for inter-individual variation in isoniazid-induced toxicological response.
    Cunningham K; Claus SP; Lindon JC; Holmes E; Everett JR; Nicholson JK; Coen M
    J Proteome Res; 2012 Sep; 11(9):4630-42. PubMed ID: 22873827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A metabonomic approach for mechanistic exploration of pre-clinical toxicology.
    Coen M
    Toxicology; 2010 Dec; 278(3):326-40. PubMed ID: 20699110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HILIC-UPLC-MS for exploratory urinary metabolic profiling in toxicological studies.
    Spagou K; Wilson ID; Masson P; Theodoridis G; Raikos N; Coen M; Holmes E; Lindon JC; Plumb RS; Nicholson JK; Want EJ
    Anal Chem; 2011 Jan; 83(1):382-90. PubMed ID: 21142126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression levels of pituitary tumor transforming 1 and glutathione-S-transferase theta 3 are associated with the individual susceptibility to D-galactosamine-induced hepatotoxicity.
    Yun JW; Kim CW; Bae IH; Park YH; Chung JH; Lim KM; Kang KS
    Toxicol Appl Pharmacol; 2010 Jan; 242(1):91-9. PubMed ID: 19800905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear magnetic resonance spectroscopic and principal components analysis investigations into biochemical effects of three model hepatotoxins.
    Beckwith-Hall BM; Nicholson JK; Nicholls AW; Foxall PJ; Lindon JC; Connor SC; Abdi M; Connelly J; Holmes E
    Chem Res Toxicol; 1998 Apr; 11(4):260-72. PubMed ID: 9548796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabonomics study of urine from Sprague-Dawley rats exposed to Huang-yao-zi using (1)H NMR spectroscopy.
    Liu Y; Huang R; Liu L; Peng J; Xiao B; Yang J; Miao Z; Huang H
    J Pharm Biomed Anal; 2010 May; 52(1):136-41. PubMed ID: 20061116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of pirfenidone on D-galactosamine and lipopolysaccharide-induced acute hepatotoxicity in rats.
    Wang F; Wen T; Chen XY; Wu H
    Inflamm Res; 2008 Apr; 57(4):183-8. PubMed ID: 18344059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactobacillus helveticus R0052 alleviates liver injury by modulating gut microbiome and metabolome in D-galactosamine-treated rats.
    Wang Q; Lv L; Jiang H; Wang K; Yan R; Li Y; Ye J; Wu J; Wang Q; Bian X; Yang L; Jiang X; Xie J; Lu Y; Shen J; Li L
    Appl Microbiol Biotechnol; 2019 Dec; 103(23-24):9673-9686. PubMed ID: 31713675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systems level metabolic phenotype of methotrexate administration in the context of non-alcoholic steatohepatitis in the rat.
    Kyriakides M; Hardwick RN; Jin Z; Goedken MJ; Holmes E; Cherrington NJ; Coen M
    Toxicol Sci; 2014 Nov; 142(1):105-16. PubMed ID: 25145655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of Mg-CUD against D-galactosamine-induced hepatotoxicity in rats.
    Choi JH; Kang JW; Kim DW; Sung YK; Lee SM
    Eur J Pharmacol; 2011 Apr; 657(1-3):138-43. PubMed ID: 21284943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR-based metabolic profiling identifies biomarkers of liver regeneration following partial hepatectomy in the rat.
    Bollard ME; Contel NR; Ebbels TM; Smith L; Beckonert O; Cantor GH; Lehman-McKeeman L; Holmes EC; Lindon JC; Nicholson JK; Keun HC
    J Proteome Res; 2010 Jan; 9(1):59-69. PubMed ID: 19445528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMR-based metabonomic and quantitative real-time PCR in the profiling of metabolic changes in carbon tetrachloride-induced rat liver injury.
    Li X; Zhang F; Wang D; Li Z; Qin X; Du G
    J Pharm Biomed Anal; 2014 Feb; 89():42-9. PubMed ID: 24252724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An insight into the metabolic responses of ultra-small superparamagnetic particles of iron oxide using metabonomic analysis of biofluids.
    Feng J; Liu H; Zhang L; Bhakoo K; Lu L
    Nanotechnology; 2010 Oct; 21(39):395101. PubMed ID: 20820093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of globin digest on the liver injury and hepatic gene expression profile in galactosamine-induced liver injury in SD rats.
    Yamamoto K; Sasakawa Y; Nakaoka F; Nakao M; Nakamura M; Kominami A; Abe M; Fukuhama C; Kagawa K
    Life Sci; 2011 Apr; 88(15-16):701-12. PubMed ID: 21334349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolite profiling and pathway analysis of acute hepatitis rats by UPLC-ESI MS combined with pattern recognition methods.
    Wang X; Lv H; Zhang A; Sun W; Liu L; Wang P; Wu Z; Zou D; Sun H
    Liver Int; 2014 May; 34(5):759-70. PubMed ID: 24004042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMR-based metabonomic analysis of the hepatotoxicity induced by combined exposure to PCBs and TCDD in rats.
    Lu C; Wang Y; Sheng Z; Liu G; Fu Z; Zhao J; Zhao J; Yan X; Zhu B; Peng S
    Toxicol Appl Pharmacol; 2010 Nov; 248(3):178-84. PubMed ID: 20691717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoniazid-induced hepatotoxicity and neurotoxicity in rats investigated by
    Ruan LY; Fan JT; Hong W; Zhao H; Li MH; Jiang L; Fu YH; Xing YX; Chen C; Wang JS
    Toxicol Lett; 2018 Oct; 295():256-269. PubMed ID: 29936297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.